These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18260850)

  • 41. Opportunistic access: Successful retrograde guide wire advancement to the pocket through a track created by laser lead extraction.
    Spragg DD; Brinker JA; Henrikson CA
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1315-6. PubMed ID: 17100692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arrhythmogenic Right Ventricular Cardiomyopathy Caused by a Novel Frameshift Mutation.
    Refaat MM; Tang P; Harfouch N; Wojciak J; Kwok PY; Scheinman M
    Card Electrophysiol Clin; 2016 Mar; 8(1):217-21. PubMed ID: 26920198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
    Wichter T; Breithardt G
    J Am Coll Cardiol; 2005 Feb; 45(3):409-11. PubMed ID: 15680720
    [No Abstract]   [Full Text] [Related]  

  • 44. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
    J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrical storm in a patient with arrhythmogenic right ventricular cardiomyopathy and SCN5A mutation.
    Erkapic D; Neumann T; Schmitt J; Sperzel J; Berkowitsch A; Kuniss M; Hamm CW; Pitschner HF
    Europace; 2008 Jul; 10(7):884-7. PubMed ID: 18375968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternative technique for implanting an epicardial cardioverter defibrillation patch during a tricuspid valve replacement for arrhythmogenic right ventricular cardiomyopathy.
    Yoda M; Tanabe H; Kishi M; Suma H
    Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):628-30. PubMed ID: 21220415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laser-assisted extraction of pacemaker and defibrillator leads: the role of the cardiac surgeon.
    Gaca JG; Lima B; Milano CA; Lin SS; Davis RD; Lowe JE; Smith PK
    Ann Thorac Surg; 2009 May; 87(5):1446-50; discussion 1450-1. PubMed ID: 19379883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of a coronary sinus lead and biventricular ICD to correct a sensing abnormality in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Bilchick KC; Judge DP; Calkins H; Marine JE
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):317-20. PubMed ID: 16643408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolated left ventricular arrhythmogenic dysplasia.
    Galvão Braga C; Silva P; Salgado A; Magalhães S; Themudo R
    Eur Heart J Cardiovasc Imaging; 2014 Aug; 15(8):907. PubMed ID: 24562184
    [No Abstract]   [Full Text] [Related]  

  • 51. Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Peters S; Truemmel M; Koehler B
    J Cardiovasc Med (Hagerstown); 2012 May; 13(5):295-8. PubMed ID: 22450866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors.
    Chung FP; Li HR; Chong E; Pan CH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin WY; Shaw KP; Chen SA
    Heart Rhythm; 2013 Dec; 10(12):1859-66. PubMed ID: 24080066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of ICD's for the treatment of patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD).
    Fontaine G
    J Interv Card Electrophysiol; 1997 Dec; 1(4):329-30. PubMed ID: 9869989
    [No Abstract]   [Full Text] [Related]  

  • 54. Arrhythmogenic right ventricular cardiomyopathy 2012: diagnostic challenges and treatment.
    Marcus FI; Abidov A
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1149-53. PubMed ID: 22909229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
    J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A pediatric case report on arrhythmogenic right ventricular dysplasia.
    Chan EL; Shannon KM; Klitzner TS
    Congenit Heart Dis; 2008; 3(2):132-7. PubMed ID: 18380763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management.
    Sen-Chowdhry S; Lowe MD; Sporton SC; McKenna WJ
    Am J Med; 2004 Nov; 117(9):685-95. PubMed ID: 15501207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of sudden cardiac deaths in arrhythmogenic right ventricular cardiomyopathy: how to evaluate risk and when to implant a cardioverter-defibrillator?
    Woźniak O; Włodarska EK
    Cardiol J; 2009; 16(6):588-91. PubMed ID: 19950101
    [No Abstract]   [Full Text] [Related]  

  • 59. Substrate-based catheter ablation in previously undiagnosed arrhythmogenic right ventricular dysplasia by means of an electroanatomic mapping system using cutaneous patches.
    Shalganov TN; Traykov VB; Protich MM; Dinov BB; Balabanski TL; Aleksieva KA
    Cardiol J; 2008; 15(6):567-8. PubMed ID: 19039764
    [No Abstract]   [Full Text] [Related]  

  • 60. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.